Elacestrant With Everolimus for the Treatment of Recurrent Advanced or Metastatic ER-Positive Endometrial Cancer

Clinical trial NCT07634601 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07634601
Sponsor: Jonsson Comprehensive Cancer Center
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Endometrial Carcinoma Metastatic Endometrial Carcinoma Recurrent Endometrial Carcinoma Stage III Endometrial Cancer Stage IV Endometrial Cancer

Start date: 2026-12-18
Primary completion: 2028-12-18
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.